The role transition of radiotherapy for the treatment of liver cancer in the COVID-19 era

The uncontrollable COVID-19 crises in the SARS-CoV-2 high-prevalence areas have greatly disrupted the routine treatment of liver cancer and triggered a role transformation of radiotherapy for liver cancer. The weight of radiotherapy in the treatment algorithm for liver cancer has been enlarged by th...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zheng, Hu, Yue, Zeng, Ming, Hu, Qinyong, Ye, Fei, Liu, Ruifeng, Cai, Hongyi, Li, Qiang, Wang, Xiaohu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516283/
https://www.ncbi.nlm.nih.gov/pubmed/36185295
http://dx.doi.org/10.3389/fonc.2022.976143
Descripción
Sumario:The uncontrollable COVID-19 crises in the SARS-CoV-2 high-prevalence areas have greatly disrupted the routine treatment of liver cancer and triggered a role transformation of radiotherapy for liver cancer. The weight of radiotherapy in the treatment algorithm for liver cancer has been enlarged by the COVID-19 pandemic, which is helpful for the optimal risk-benefit profile.

Ejemplares similares